G. Magro

SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc

Giuseppe Magro, G. Magro, 2020, Cytokine: X.

Reversible dementia and insomnia in ABGA related encephalitis.

G. Magro, L. Mumoli, E. Le Piane, 2024, Sleep medicine.

The Dark side of the White Matter. Diffuse subcortical White Matter Hypointensity on T2/FLAIR: A systematic review of a frequently underrecognized sign

Vincenzo Laterza, G. Magro, Federico Tosto, 2024, Journal of the Neurological Sciences.

COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking

Giuseppe Magro, G. Magro, 2020, Virus Research.